Kamisha L Johnson-Davis Selected Research

Kamisha L Johnson-Davis Research Topics

Disease

4	Seizures (Absence Seizure) 01/2024 - 08/2011
3	Chronic Pain 01/2018 - 01/2014
3	Hyperthermia 03/2007 - 12/2003
2	Schizophrenia (Dementia Praecox) 01/2024 - 01/2016
2	Multiple Sclerosis 01/2019 - 01/2016
2	Rheumatoid Arthritis 01/2019 - 01/2016
2	Mental Disorders (Mental Disorder) 01/2016 - 11/2015
2	Neuralgia (Stump Neuralgia) 01/2014 - 04/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	COVID-19 01/2023
1	Lennox Gastaut Syndrome 04/2022
1	Rare Diseases (Rare Disease) 03/2022
1	Malnutrition (Nutritional Deficiencies) 08/2020
1	Infections 01/2019
1	Neoplasms (Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Pain (Aches) 11/2015
1	Epilepsy (Aura) 09/2011
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 06/2011
1	Body Weight (Weight, Body) 06/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011
1	Atherosclerosis 01/2011
1	Chronic Renal Insufficiency 01/2011
1	Renal Insufficiency (Renal Failure) 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2005
1	Parkinson Disease (Parkinson's Disease) 09/2005

Drug/Important Bio-Agent (IBA)

4	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2007 - 12/2003
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2024 - 01/2021
2	Cytochrome P-450 CYP3AIBA 01/2023 - 12/2016
2	BenzodiazepinesIBA 04/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2019
2	teriflunomideIBA 01/2019 - 01/2016
2	EnzymesIBA 02/2015 - 01/2011
2	Gabapentin (Neurontin)FDA LinkGeneric 08/2011 - 04/2011
1	Olanzapine (Zyprexa)FDA Link 01/2024
1	Ritonavir (Norvir)FDA Link 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Clobazam (HR 376)IBA 04/2022
1	eslicarbazepine acetateIBA 01/2021
1	MetalsIBA 08/2020
1	DNA Transposable Elements (Element, IS)IBA 08/2020
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Opiate AlkaloidsIBA 01/2018
1	Tamoxifen FDA LinkGeneric 12/2016
1	Cytochrome P-450 CYP2C9IBA 12/2016
1	Cytochrome P-450 CYP2C19IBA 12/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2016
1	Fluphenazine (Prolixin)FDA LinkGeneric 01/2016
1	Anti-Arrhythmia AgentsIBA 01/2016
1	Flecainide (Tambocor)FDA LinkGeneric 01/2016
1	Mexiletine (Mexitil)FDA LinkGeneric 01/2016
1	Leflunomide (Arava)FDA LinkGeneric 01/2016
1	ProdrugsIBA 01/2016
1	Propafenone (Rythmol)FDA LinkGeneric 01/2016
1	Haloperidol (Haldol)FDA LinkGeneric 01/2016
1	Thiothixene (Navane)FDA LinkGeneric 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2016
1	Perphenazine (Trilafon)FDA LinkGeneric 01/2016
1	Ethanol (Ethyl Alcohol)IBA 11/2015
1	Illicit Drugs (Recreational Drugs)IBA 11/2015
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2014
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2011
1	Busulfan (Busulfex)FDA Link 06/2011
1	AntioxidantsIBA 01/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 09/2005

Therapy/Procedure

5	Therapeutics 01/2024 - 08/2011
1	Drug Therapy (Chemotherapy) 01/2018
1	Renal Dialysis (Hemodialysis) 01/2011
1	Peritoneal Dialysis 01/2011
1	Induced Hyperthermia (Thermotherapy) 03/2007